Kyselovic, J.; Adamičková, A.; Gažová, A.; Valášková, S.; Chomaničová, N.; Červenák, Z.; Madaric, J.
Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with “No-Option” Critical Limb Ischaemia. Biomedicines 2024, 12, 922.
https://doi.org/10.3390/biomedicines12040922
AMA Style
Kyselovic J, Adamičková A, Gažová A, Valášková S, Chomaničová N, Červenák Z, Madaric J.
Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with “No-Option” Critical Limb Ischaemia. Biomedicines. 2024; 12(4):922.
https://doi.org/10.3390/biomedicines12040922
Chicago/Turabian Style
Kyselovic, Jan, Adriana Adamičková, Andrea Gažová, Simona Valášková, Nikola Chomaničová, Zdenko Červenák, and Juraj Madaric.
2024. "Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with “No-Option” Critical Limb Ischaemia" Biomedicines 12, no. 4: 922.
https://doi.org/10.3390/biomedicines12040922
APA Style
Kyselovic, J., Adamičková, A., Gažová, A., Valášková, S., Chomaničová, N., Červenák, Z., & Madaric, J.
(2024). Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with “No-Option” Critical Limb Ischaemia. Biomedicines, 12(4), 922.
https://doi.org/10.3390/biomedicines12040922
